Cite

Clinical applications of microarray technology: creatine kinase B is an up-regulated gene in epithelial ovarian cancer and shows promise as a serum marker

MLA

Huddleston, Heather G., et al. “Clinical Applications of Microarray Technology: Creatine Kinase B Is an up-Regulated Gene in Epithelial Ovarian Cancer and Shows Promise as a Serum Marker.” Gynecologic Oncology, vol. 96, no. 1, Jan. 2005, pp. 77–83. EBSCOhost, https://doi.org/10.1016/j.ygyno.2004.08.047.



APA

Huddleston, H. G., Wong, K., Welch, W. R., Berkowitz, R. S., & Mok, S. C. (2005). Clinical applications of microarray technology: creatine kinase B is an up-regulated gene in epithelial ovarian cancer and shows promise as a serum marker. Gynecologic Oncology, 96(1), 77–83. https://doi.org/10.1016/j.ygyno.2004.08.047



Chicago

Huddleston, Heather G., Kwong-kwok Wong, William R. Welch, Ross S. Berkowitz, and Samuel C. Mok. 2005. “Clinical Applications of Microarray Technology: Creatine Kinase B Is an up-Regulated Gene in Epithelial Ovarian Cancer and Shows Promise as a Serum Marker.” Gynecologic Oncology 96 (1): 77–83. doi:10.1016/j.ygyno.2004.08.047.